Research Library

Scientists and members of the public exploring the controversial area of U.S. human embryo and embryoid research will find a complex and sometimes bewildering assortment of federal and state laws. The authors recommend additional guidance, but note slow progress in the development of embryo research policy.

A team of experts recommends community-based strategies for increasing vaccine acceptance in the USA as a means for controlling the COVID-19 pandemic.

Hospital at Home programs offer an alternative care model for acutely ill patients to receive intensive at-home treatment. With better policy and operations, can this model work at scale in the United States beyond the pandemic?

Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.

To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.

Global deworming programs for children were once believed to improve a child’s chances for health, growth and success in school. New research that claims to debunk the merit of such programs has set off so-called “worm wars” between investigators. The authors aim to resolve the issue through an extended comparison of findings from key economics and epidemiological studies.

The authors discuss Pakistan’s challenges with neglected tropical diseases (NTDs) and their impact on poverty, child development and overall health in the country.

Treating intestinal worm infections leads to improved human development and childhood education, shows a study by Center for Health & Biosciences postdoctoral fellow SuJin Kang and fellows Peter Hotez and Farhan Majid.